This paper reviews recent psychological studies of patients with the irritable bowel syndrome (IBS) or 'functional abdominal pain'. Many studies have used unreliable or invalid methods of assessment and some have confused personality with treatable psychiatric illness. Reliable and valid measures have indicated that 40-500/o of patients with recently diagnosed functional abdominal pain have dem...

A significant proportion of patients worldwide diagnosed with irritable bowel syndrome (IBS) experience comorbid psychiatric conditions, depression being the most prevalent disorder among them. In Western countries, prevalence mental disorders IBS ranges between 40% and 60%. However, in Asian such as India, rates are even higher, exceeding 80% individuals IBS. The disease is mostly studied regi...

CONDITIONS: Half of the irritable bowel syndrome patients received an exclusion diet that took into account the individual food incompatibilities (detectable by means of a test for food-specific IgG antibodies). The other irritable bowel syndrome patients received a sham diet that did not take into account any incompatibilities. The following symptoms were measured: deterioration and improvemen...

Submit Manuscript | http://medcraveonline.com Abbreviations: Apo E: Apolipoprotein E; DC: Dendritic Cell; FODMAPs: Fermentable Oligosaccharides, Disaccharides, Monosaccharide And Polyols; GALT: Gut-Associated Lymphoid Tissue; HFD: High-Fat Diet; IBD: Inflammatory Bowel Disease; IBS: Irritable Bowel Syndrome; IR: Insulin Resistance; LcS: Lactobacillus Casei Shirota; MAdCAM-1: Mucosal Address in ...

Irritable bowel syndrome (IBS) accounts for 25% of gastroenterology output practice, making it one of the most common disorders in this practice. Psychological and social factors may affect the development of this chronic disorder. Furthermore, psychiatric symptoms and psychiatric diseases are highly prevalent in this condition, but the approach to treating these is not always straightforward. ...

Irritable bowel syndrome (IBS) is a functional disorder of the gastrointestinal system characterized by abdominal pain related to bowel emptying, defecation impairment and abdominal distention. The aim of the study was to objectify lower gastrointestinal system disturbances in IBS patients. Thirty IBS patients and 30 healthy subjects were included in the study. IBS patients were divided into tw...

BACKGROUND Irritable bowel syndrome (IBS) is a worldwide disease with high morbidity. The effect of current treatment with Western medicine is not satisfactory. Although moxibustion treatment is widely used for gastrointestinal diseases, randomized controlled trials on the use of this treatment for IBS are limited. This study aims to evaluate the clinical efficacy and safety of moxibustion trea...

This paper reviews recent psychological studies of patients with the irritable bowel syndrome (IBS) or 'functional abdominal pain'. Many studies have used unreliable or invalid methods of assessment and some have confused personality with treatable psychiatric illness. Reliable and valid measures have indicated that 40-500/o of patients with recently diagnosed functional abdominal pain have dem...

BACKGROUND & AIMS Irritable bowel syndrome (IBS) is a chronic and disabling gastrointestinal disorder. Although considerable research has underlined the influence of coping mechanisms as the determinants of the quality of life (QOL), only limited data are available regarding the specific coping mechanisms used by IBS patients to manage illness in daily life. Irrational cognitions are known to e...

INTRODUCTION Few therapeutic options are available for irritable bowel syndrome (IBS). Lubiprostone is approved by the FDA for IBS with constipation, and alosetron in IBS with diarrhea (IBS-D). It has been proposed that alterations in the bowel microflora may play a role in the pathophysiology of IBS, and that modulation of the microflora holds therapeutic potential. Rifaximin is a nonsystemic ...